Summary
Synopsys, Inc. (SNPS) reported its financial results for the fiscal second quarter ended January 31, 2023. The company demonstrated robust revenue growth of 7%, reaching $1.36 billion, primarily driven by an 11% increase in its Design Automation segment. This growth was supported by strong performance in time-based product revenue, which rose 11%. While overall revenue increased, the Design IP segment saw a 4% decrease, and the Software Integrity segment experienced a significant 19% jump. Net income for the quarter was $268.6 million, a decrease from the prior year's $313.3 million, resulting in diluted earnings per share of $1.75, down from $1.99 in the comparable period. The company continues to invest heavily in research and development, with expenses increasing by 21% year-over-year, reflecting its commitment to innovation and expanding its product portfolio. Synopsys also initiated a restructuring plan in Q1 FY23, resulting in charges of $40.9 million. Despite these investments and charges, the company maintained a strong financial position, ending the quarter with $1.3 billion in cash, cash equivalents, and short-term investments. The company also continued its share repurchase program, with $1.1 billion remaining available for future repurchases.
Financial Highlights
57 data points| Revenue | $1.36B |
| Cost of Revenue | $284.35M |
| Gross Profit | $1.08B |
| R&D Expenses | $465.33M |
| Operating Expenses | $821.05M |
| Operating Income | $255.93M |
| Interest Expense | $264K |
| Net Income | $271.54M |
| EPS (Basic) | $1.78 |
| EPS (Diluted) | $1.75 |
| Shares Outstanding (Basic) | 152.40M |
| Shares Outstanding (Diluted) | 155.08M |
Key Highlights
- 1Total revenue increased by 7% to $1.36 billion, driven by a strong performance in the Design Automation segment.
- 2Net income decreased by 14% to $268.6 million, with diluted EPS falling to $1.75 from $1.99 year-over-year.
- 3Research and Development expenses saw a significant increase of 21% to $465.3 million, indicating continued investment in innovation.
- 4The company initiated a restructuring plan in the first quarter of fiscal year 2023, incurring charges of $40.9 million.
- 5Synopsys maintained a healthy liquidity position with $1.3 billion in cash, cash equivalents, and short-term investments as of January 31, 2023.
- 6The Design IP segment experienced a revenue decline of 4%, while the Software Integrity segment saw a robust increase of 19%.
- 7Share repurchases continued, with $1.1 billion remaining under the authorized program as of quarter-end.